EEG Motor Movement and Imagery Dataset for Stroke

Sponsor
Xuanwu Hospital, Beijing (Other)
Overall Status
Recruiting
CT.gov ID
NCT05499442
Collaborator
(none)
120
1
24
5

Study Details

Study Description

Brief Summary

The investigators collect and analyze the alpha and beta wave of EEG activity at the motor cortices of the participants, When the motor task is being performed. The Brodmann area 10-20 method and portable EEG equipment was used in the single-center study.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To understand the motor mechanism of stroke patients with motor dysfunction, an EEG motor movement and imagery dataset for Stroke will be created. 120 subjects will be enrolled in the single-center study. The investigators collect and analyze the EEG activity at the motor cortices of the participants, When the motor movement or imagery task is being performed. The alpha and beta wave of EEGs were recorded from 32 electrodes as per the international 10-20 system with portable EEG equipment.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    120 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Construction of Non-invasive EEG Motor Movement and Imagery Dataset for Stroke
    Actual Study Start Date :
    Jan 1, 2022
    Anticipated Primary Completion Date :
    Dec 1, 2023
    Anticipated Study Completion Date :
    Dec 31, 2023

    Outcome Measures

    Primary Outcome Measures

    1. EEG characteristics of motor [1-7day]

      EEG Characteristics for Motor Execution and Motor Imagery

    2. Action Research Arm Test [1-7days]

      Use the assessment scale of Action Research Arm Test evaluation completes the limb function evaluation

    3. Fugl-meyer Assessment [1-7days]

      Use the assessment scale of Fuel-meyer to evaluate completes the limb function evaluation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. The diagnosis of cerebral infarction conforms to the diagnostic criteria of Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2018, and the diagnosis of intracerebral hemorrhage conforms to the diagnostic criteria of Chinese guidelines for the diagnosis and treatment of intracerebral hemorrhage 2019.

    2. First onset.

    3. Age ≥ 18 years old.

    4. Motor dysfunction of upper and / or lower limbs: muscle strength decreased by 0 to 5-grade and / or ataxia.

    5. Informed consent has been signed.

    Exclusion Criteria:
    1. Vital signs are unstable.

    2. Serious circulatory system, respiratory system, motor system and other diseases, such as atrial fibrillation, heart failure, pulmonary infection, severe liver and kidney insufficiency, lower extremity venous thrombosis and other serious diseases.

    3. Functional impairment of upper or lower limbs caused by other diseases of nervous system or other reasons, such as fracture, deformity, etc.

    4. Unable to cooperate to complete the examination, such as mental disorder, cognitive impairment, visual impairment, sitting balance disorder, etc

    5. Other reasons: alcoholism; Skull defect; Head skin defect, etc.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Xuanwu Hospital, Beijing Beijing Beijing China 100053

    Sponsors and Collaborators

    • Xuanwu Hospital, Beijing

    Investigators

    • Principal Investigator: Junwei Hao, Xuanwu Hospital, Beijing

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Xuanwu Hospital, Beijing
    ClinicalTrials.gov Identifier:
    NCT05499442
    Other Study ID Numbers:
    • haojunwei8
    First Posted:
    Aug 12, 2022
    Last Update Posted:
    Aug 12, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 12, 2022